Thanks to Power3 Medical Products Inc. (OTCBB:PWRM), people with Alzheimer’s may be able to say, thanks for the memory. Power3 recently made four poster presentations at the 2010 International Conference on Alzheimer's Disease (NASDAQ:ICAD) in Honolulu, Hawaii. The leading proteomics company, which is focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, discussed NuroPro®, Power3's diagnostic test, and highlighted Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
"We are pleased that our blood tests specifically diagnose Alzheimer's in patients, both pre- and post-treatment," said Helen R. Park, MS, Chief Executive Officer of Power3, "and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii."
"We are within striking distance of realizing an Alzheimer's clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions," added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.
Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which it is currently engaged in Phase II clinical trials.
Barnes & Noble, Inc. (NYSE:BKS), the world’s largest bookseller, released the November line-up for the “More in Store” program for the NOOK family of eBook Readers. Available only in Barnes & Noble stores and only on NOOK, the free More in Store program offers NOOK customers new, exclusive content from bestselling and new authors, special offers and savings, and weekly bestseller and new release lists.
The Barnes & Noble More in Store for NOOK November line-up includes: November 7 - The Tiger by Pat Conroy and There’s a Reason It’s Not Called Thankstaking by Ellen Rogers; November 14- What It Took by Cecily von Ziegesar and Top Five Foodie Destinations in Italy by Frances Mayes; November 21- How Not to Look Like a Frump, Tart or Freak by Clinton Kelly and Read Pink! by Eloisa James; and November 28- Being Grateful for the Little Things by Lesley M. M. Blume and The Top Five Questions Parents Ask by John Medina.
Barnes & Noble, Inc., together with its subsidiaries, operates as a bookseller in the United States. Barnes & Noble provides access to books, magazines, newspapers, and other content across its multi-channel distribution platform.
Endwave Corporation (Nasdaq:ENWV), a leading provider of high-frequency RF solutions and semiconductor products for the telecommunications, satellite communications, electronic instruments and defense and security markets, recently reported financial results for its third quarter, which ended on September 30, 2010.
Revenues for the third quarter of 2010 were $4.1 million. This compares with revenues of $3.8 million in the prior quarter and $3.1 million in the third quarter of fiscal 2009. Net loss, calculated in accordance with accounting principles generally accepted in the United States (GAAP), for the third quarter of 2010 was $2.0 million, or $0.20 per share. This compares with a net loss of $2.8 million, or $0.29 per share in the prior quarter, and a net loss of $2.6 million or $0.27 per share in the third quarter of fiscal 2009.
Endwave Corporation designs, manufactures and markets high frequency RF solutions and semiconductor products that enable the transmission, reception and processing of high-frequency signals in the telecommunications, satellite communications, electronic instruments and defense and security markets.
Modine Manufacturing Company (NYSE:MOD), a diversified global leader in thermal management technology and solutions, reported its financial results for the second quarter ended September 30, 2010. Highlights include: Sales were $346 million, up 23 percent from the same period last year; Gross margin of 16.7 percent improved 170 basis points year over year; Operating income of $11.2 million represented a 140 percent improvement from the prior year; Long-term debt refinancing was completed in August 2010; and Adjusted EBITDA was $26.6 million, an increase of 17 percent from the prior year.
Modine specializes in thermal management systems and components, bringing highly engineered heating and cooling technology and solutions to diversified global markets. Modine products are used in light, medium and heavy-duty vehicles, heating, ventilation and air conditioning equipment, off-highway and industrial equipment, refrigeration systems, and fuel cells.
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).